Clinical Trials Directory

Trials / Terminated

TerminatedNCT02110277

Photoacoustic Imaging of the Ovary

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
UConn Health · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop technology to image the ovaries in order to better evaluate ovarian disease and to study how these experimental imaging techniques might work together or separately to improve our ability to detect ovarian cancer.

Detailed description

Epithelial ovarian cancer causes the highest mortality of any of the gynecologic cancers although it is the second most common gynecologic malignancy. Ovarian cancer is not usually detected earlier than Stage III or IV because it is usually asymptomatic; yet survival is high with early stage disease. In addition, women with a pelvic mass noted on ultrasound that undergo oophorectomy have only a 1-3% risk of malignancy and thus 97-99% will be overtreated because of our inability to reliably differentiate benign from malignant masses with ultrasound. BRCA1 testing and family history will identify certain high-risk individuals who have a higher risk of malignancy and need a modality that will be more reliable in detecting early cancers to provide more accurate surveillance.We are developing a new transvaginal imaging device optimized for ovarian cancer detection, diagnosis and validated from ex vivo and in vivo clinical studies. This automated system may provide an early diagnostic tool for ovarian cancer in the future.

Conditions

Interventions

TypeNameDescription
DEVICEPAI/ultrasound Diagnostic GroupThese patients will include women who are at risk for ovarian cancer and wish to undergo prophylactic oophorectomy, or who have an ovarian mass suggestive of a malignancy and are counseled to undergo oophorectomy.

Timeline

Start date
2014-03-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2014-04-10
Last updated
2018-03-13
Results posted
2018-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02110277. Inclusion in this directory is not an endorsement.